What are the RMOCs?

The four Regional Medicines Optimisation Committees for England make recommendations, pursue actions, and co-ordinate activities related to any aspect of Medicines Optimisation.  There is a committee for each NHS England region which brings together decision makers and clinicians across each geography.

Although there are four committees, the RMOCs operate against a single framework, with each group being part of a greater national system.  Their role and function has been co-developed by NHS England and NHS Clinical Commissioners on behalf of Clinical Commissioning Groups, in partnership with NHS hospital representatives, primary care providers, the National Institute for Health and Care Excellence, NHS Improvement and representative bodies of the branded and generic pharmaceutical industry.

Overall governance for the RMOC system is provided through the Medicines Optimisation Oversight Group (MOOG).  Generation of the work programme and national priority setting is provided through the Medicines Optimisation Priorities Panel (MOPP).  Both the MOOG and the MOPP are chaired by the Chief Pharmaceutical Officer for England, Dr Keith Ridge CBE.

More detail about how the Regional Medicines Optimisation Committees work is also available in the operating model, which is published here.